Here's Why Clearbridge Growth Strategy Sold AbbVie (ABBV)

By Yahoo! Finance   |   1 month ago
Here's Why Clearbridge Growth Strategy Sold AbbVie (ABBV)

ClearBridge Investments released its Q1 2025 investor letter discussing the market correction and the outperformance of mid cap growth stocks. AbbVie Inc. was highlighted as a stock with potential, despite challenges. The company's recent performance and strategic decisions were also noted.

Read More

Did you find this insightful?